title: Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide. Concluding comments.
authors.affiliation: Institute of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Via Balzaretti 9, 20133 Milan, Italy. Electronic address: alberico.catapano@unimi.it.
authors.forename: Alberico L
authors.initials: AL
authors.lastname: Catapano
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D001781:Blood Component Removal / Q000379:methods*; D008078:Cholesterol, LDL / Q000097:blood; D032921:Consensus; D019468:Disease Management; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy*; D008019:Life Style
chemical_list: C473731:BMS201038; D001562:Benzimidazoles; D008078:Cholesterol, LDL
keywords: Apheresis; Drug–drug interactions; Homozygous familial hypercholesterolaemia; Lomitapide; Transaminase elevations